What drug treatment measures should be taken after dasatinib resistance?

When resistance to dasatinib occurs, other drugs can first be considered for treatment. According to publicly released information, drugs such as imatinib and nilotinib are effective drugs for the treatment of chronic myelogenous leukemia and can inhibit the growth of tumor cells in the body. These drugs may be effective alternative treatments after dasatinib resistance.

If one drug alone is not effective in controlling the disease, a combination of two or more drugs may be an effective strategy. For example, the combined use of axitinib, sunitinib and other drugs can be considered to enhance the therapeutic effect. Combination therapy may help overcome drug resistance and improve disease control rates.

In some cases, increasing the dose of the drug may help restore the drug's inhibitory effect on tumor cells. Of course, this needs to be done under the guidance of a doctor to ensure the safety and effectiveness of the medication. Adjustment of dosage may be a simple and effective strategy but also requires close monitoring of patient response and tolerability.

If the above methods still fail to effectively relieve symptoms, patients can also consider local treatments such as radioactive seed implantation. This treatment helps kill cancer cells and improves quality of life. However, local treatments such as radiotherapy are often used as adjuvant treatments in combination with systemic drug treatments to achieve the best therapeutic effect.

For patients with strong drug resistance, you can also consider participating in clinical trials or new drug research. These studies may provide new treatment strategies or drugs, giving patients more treatment options. Of course, participation in clinical trials requires a full understanding and acceptance of the associated risks.